Study will evaluate the role of smart devices on monitoring cognitive health
News
ICR researchers identify potential new treatment for drug-resistant prostate cancer
CCS1477 has a novel mechanism of action compared to existing treatments
DHSC publishes ‘UK Rare Disease Framework’
Framework identifies four key priorities and five ‘underpinning themes’
UK government unveils ‘largest vaccination programme in British history’
Plan aims to rapidly scale-up COVID-19 vaccination programme
Boehringer Ingelheim announces partnership with Google
Partnership will aim to research and implement quantum computing in pharma R&D
EU OK for Roche’s oral flu treatment Xofluza
Oral treatment approved to treat uncomplicated influenza and for post-exposure prophylaxis
Sanofi to acquire Kymab for up to $1.45bn
Acquisition will add monoclonal antibody KY1005 to Sanofi’s pipeline
England to launch rapid asymptomatic COVID-19 testing this week
Testing will be aimed at people who cannot work from home during national lockdown
BREAKING NEWS: Moderna’s COVID-19 vaccine granted authorisation in UK
Third vaccine to receive approval from the UK’s MHRA
MHRA review recommends discussion around epilepsy medication and pregnancy
Women taking epilepsy medication who may be pregnant urged to discuss treatment options
Tocilizumab and sarilumab cut risk of death in severe COVID-19 patients
Anti-inflammatory drugs also accelerated patients’ recovery times
NHS Digital pilot will collect private hospital data
Pilot will be led by NHS Digital and the Private Healthcare Information Network
NICE no for BMS’ Opdivo for head and neck cancer
Opdivo is currently available on the Cancer Drugs Fund
Back-to-back winner reveals the exceptional challenges and rewards in the International Clinical Researcher of the Year competition
The prestigious PharmaTimes INTCR competition has amassed a strong following since its introduction over two decades ago, with many of the fantastic finalists eager to show their support.
New COVID-19 drug screening hub established in Scotland
Life Arc funds hub based at the University of Glasgow
